← 홈

ADC

505개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 505개
ADCBiologicHoffmann-La RochePhase 2

Xeloda (Xeloda)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 30%임상시험 65상태 RECRUITING
ADCBiologicCaicun ZhouSN-38, indicated by higher …Phase 2

Gefitinib (Gefitinib)

Non-small-cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 74.9%임상시험 64상태 ACTIVE
ADCBiologicAstraZenecaPhase 3

Pemetrexed/Cisplatin (Pemetrexed/Cisplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 87.5%임상시험 64상태 RECRUITING
ADCBiologicChia Tai Tianqing Pharmaceutica…Deruxtecan in Patients With…Phase 3

Taxane (Taxane)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 36%임상시험 64상태 RECRUITING
ADCBBiologicShanghai Junshi Bioscience Co.,…Phase 2

XELOX (XELOX)

Metastatic HER2 Positive Gastroesophageal Junction Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 47%임상시험 64상태 RECRUITING
ADCBiologicJiangsu Tasly Diyi Pharmaceutic…Phase 2

vinorelbine tartrate (vinorelbine tartrate)

Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer · Adult Lymphocyte Depletion Hodgkin Lymph

#AdultLymphocyteDepletionHodgkinL#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 32%임상시험 64상태 ACTIVE
ADCBiologicSuzhou Transcenta Therapeutics …DM1) leading to diabetic ke…Phase 2

Albumin-Paclitaxel (Albumin-Paclitaxel)

Non-small Cell Lung Cancer Metastatic; First-line Treatment · Breast Cancer Early Stage Breast Cancer

#BreastCancerEarlyStageBreastCanc#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.5%임상시험 63상태 RECRUITING
ADCBiologicSanofireleasePhase 2

Anthracycline (Anthracycline)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 63상태 RECRUITING
ADCBiologicRocheDM1 via butelase-1 with ABD…Phase 3

Kadcyla, T-DM1 (Control drug: Trastuzumab emtansine, Control drug: Trastuzumab emtansine (Kadcyla, T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 79.7%임상시험 63상태 ACTIVE
ADCBiologicAstraZenecaPhase 2

Selumetinib (Selumetinib)

Advanced Pancreatic Ductal Adenocarcinoma; Metastatic Pancreatic Ductal Adenocarcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 19.7%임상시험 63상태 RECRUITING
ADCCBiologicRemeGen Co., Ltd.Phase 3

Capecitabine tablets (Capecitabine tablets)

Breast Cancer · Recurrent or Metastatic Nasopharyngeal C

#RecurrentorMetastaticNasopharyng#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 35.4%임상시험 62상태 ACTIVE
ADCBiologicARCAGYGovitecanPhase 2

GCSF (GCSF)

Ovarian Cancer · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 20.4%임상시험 62상태 DISCONTINUED
ADCBiologicAmer Zureikatvedotin after avelumabPhase 2

Gemcitabine (Gemzar, Gemzar (Gemcitabine))

Pancreatic Cancer · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase2#인기#항체약물접합체+5
임상시험 62상태 DISCONTINUED
ADCBiologicAstraZenecaPhase 2

Goserelin (Goserelin)

Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 31%임상시험 62상태 RECRUITING
ADCBiologicMedical Enterprises Europe B.V.Phase 3

Mitomycin C (Mitomycin C)

Locally Advanced Cancer in the Anal Region · Urothelial Cancer

#UrothelialCancer#ADC#Phase3#인기#항체약물접합체+4
임상시험 62상태 RECRUITING
ADCBiologicIgenomixPhase 2

RNA analysis (RNA analysis)

Prostate Cancer · Adult Lymphocyte Depletion Hodgkin Lymph

#AdultLymphocyteDepletionHodgkinL#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 18%임상시험 62상태 ACTIVE
ADCBiologicSuzhou Suncadia Biopharmaceutic…rezetecanPhase 3

SHR-A1811 (SHR-A1811)

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
임상시험 62상태 RECRUITING
ADCBiologicQuantumLeap Healthcare Collabor…Phase 2

Standard Therapy (Standard Therapy)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 9%임상시험 62상태 RECRUITING
ADCBiologicRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 77%임상시험 61상태 RECRUITING
ADCBiologicOHSU Knight Cancer InstitutePhase 1

Bicalutamide (Bicalutamide)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 19%임상시험 61상태 DISCONTINUED

4 / 26 페이지

← 이전다음 →